松田 諭

Medicine & Life Sciences

1. Esophagectomy 100%
2. Esophageal Neoplasms 99%
3. Esophageal Squamous Cell Carcinoma 66%
4. Survival 25%
5. Stomach Neoplasms 22%
6. Recurrence 21%
7. Lymph Nodes 18%
8. Lymph Node Excision 17%
9. Drug Therapy 16%
10. Gastrectomy 15%
11. Fibrinogen 15%
12. Neoplasm Metastasis 14%
13. Chemoradiotherapy 14%
14. Japan 14%
15. Thorax 12%
16. Thoracic Duct 12%
17. Postoperative Complications 11%
18. Neoadjuvant Therapy 10%
19. Neoplasms 10%
20. Sarcopenia 9%
21. Pneumonia 9%
22. Albumins 9%
23. Dissection 9%
24. Organ Preservation 7%
25. Serum Albumin 7%
26. Systematic Reviews 6%
27. Prospective Studies 6%
28. Stomach 6%
29. Lymphocytes 6%
30. Therapeutics 6%
31. C-Reactive Protein 5%
32. Psoas Muscles 5%
33. Cisplatin 5%
34. Residual Neoplasm 5%
35. Anastomotic Leak 5%
36. squamous cell carcinoma-related antigen 5%
37. CCR7 Receptors 5%
38. Peptic Esophagitis 5%
39. Cohort Studies 5%